Epidemiology, risk, myths, pharmacotherapeutic management and socio economic burden due to novel COVID-19: A recent update-Reference-Cited by-同舟云学术

Epidemiology, risk, myths, pharmacotherapeutic management and socio economic burden due to novel COVID-19: A recent update

Published:2020 Issue:9 Volume:13 Page:4435
ISSN:0974-3618
Container-title:Research Journal of Pharmacy and Technology
language:en
Short-container-title:Rese. Jour. of Pharm. and Technol.

Author:

Ahmad Sarfaraz,Shoaib Ambreen,Ali Md. Sajid,Alam Md. Sarfaraz,Alam Nawazish,Ali Maksood,Mujtaba Md. Ali,Ahmad Ayaz,Ansari Md. Salahuddin,Ali Mohammad Daud

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methods and Systems for Sharing Economic Management File Resources Based on Big Data;2024 Third International Conference on Distributed Computing and Electrical Circuits and Electronics (ICDCECE);2024-04-26

2. Comparative Analysis of Knowledge, Awareness and Practice towards rational use of face masks between healthcare and non-healthcare individuals during the COVID-19 Pandemic;Research Journal of Pharmacy and Technology;2023-09-30

3. The Impact of High D-Dimer on The Clinical Outcome of Covid-19 patients at A Private Hospital in Jakarta;Research Journal of Pharmacy and Technology;2023-08-31

4. Knowledge towards COVID-19 preventive measures, and beliefs on use of herbal products as protective measure against COVID-19 infection;Research Journal of Pharmacy and Technology;2023-08-31

5. The Impact of Body Mass Index on the Antibody Titer after Astra Zeneca Vaccination at UTA’45 Vaccine Center;Research Journal of Pharmacy and Technology;2023-06-26